Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Akebia Ther stock (AKBA)

Buy Akebia Ther stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Akebia Ther is a biotechnology business based in the US. Akebia Ther shares (AKBA) are listed on the NASDAQ and all prices are listed in US Dollars. Akebia Ther employs 167 staff and has a trailing 12-month revenue of around $187.2 million.

Our top picks for where to buy Akebia Ther stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Best for beginners

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for cash sweep

Go to site
Advanced charts and trading tools
  • Trade stocks, ETFs and equity options without commission and $0 option contract fees
  • Earn up to 8.1% APY on your uninvested cash
  • Get a 1.5% match in cash on transferred assets up to $300 or up to 15 free fractional shares worth between $2 and $2,000

How to buy Akebia Ther stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – AKBA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Akebia Ther stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Choose a 1.5% match or up to 15 free fractional shares
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Akebia Ther stock price (NASDAQ: AKBA)

Use our graph to track the performance of AKBA stocks over time.

Akebia Ther shares at a glance

Information last updated 2024-07-08.
Latest market close$1.26
52-week range$0.78 - $2.48
50-day moving average $1.13
200-day moving average $1.27
Wall St. target price$5.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.22

Is it a good time to buy Akebia Ther stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Akebia Ther price performance over time

Historical closes compared with the close of $1.26 from 2024-07-12

1 week (2024-07-05) 34.66%
1 month (2024-06-14) 17.76%
3 months (2024-04-12) -13.70%
6 months (2024-01-12) -18.71%
1 year (2023-07-14) 18.87%
2 years (2022-07-14) 189.66%
3 years (2021-07-14) 3.54
5 years (2019-07-12) 4.21

Is Akebia Ther stock undervalued or overvalued?

Valuing Akebia Ther stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Akebia Ther's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Akebia Ther's EBITDA

Akebia Ther's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4 million.

The EBITDA is a measure of a Akebia Ther's overall financial performance and is widely used to measure a its profitability.

Akebia Ther financials

Revenue TTM $187.2 million
Gross profit TTM $140 million
Return on assets TTM -8.37%
Return on equity TTM -553.45%
Profit margin -22.99%
Book value $-0.13
Market Capitalization $196.1 million

TTM: trailing 12 months

Akebia Ther share dividends

We're not expecting Akebia Ther to pay a dividend over the next 12 months.

Akebia Ther share price volatility

Over the last 12 months, Akebia Ther's shares have ranged in value from as little as $0.7801 up to $2.48. A popular way to gauge a stock's volatility is its "beta".

AKBA.US volatility(beta: 0.77)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akebia Ther's is 0.768. This would suggest that Akebia Ther's shares are less volatile than average (for this exchange).

Akebia Ther overview

Akebia Therapeutics, Inc. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent patients. It offers Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD on dialysis; and the treatment of iron deficiency anemia in adult patients with CKD not on dialysis. The company's product pipeline includes AKB-9090, a drug targeting critical-care indications; and AKB-10108, a drug targeting conditions related to premature birth. It has collaboration agreements with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of vadadustat in Japan and other Asian countries, as well as research and license agreement with Janssen Pharmaceutica NV for the development and commercialization of hypoxia-inducible factor prolyl hydroxylase targeted compounds worldwide. Akebia Therapeutics, Inc.

Frequently asked questions

What percentage of Akebia Ther is owned by insiders or institutions?
Currently 2.136% of Akebia Ther shares are held by insiders and 27.263% by institutions.
How many people work for Akebia Ther?
Latest data suggests 167 work at Akebia Ther.
When does the fiscal year end for Akebia Ther?
Akebia Ther's fiscal year ends in December.
Where is Akebia Ther based?
Akebia Ther's address is: 245 First Street, Cambridge, MA, United States, 02142
What is Akebia Ther's ISIN number?
Akebia Ther's international securities identification number is: US00972D1054
What is Akebia Ther's CUSIP number?
Akebia Ther's Committee on Uniform Securities Identification Procedures number is: 00972D105

More guides on Finder

Ask a Question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site